FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994092210> ?p ?o ?g. }

• W1994092210 endingPage "22" @default.
• W1994092210 startingPage "17" @default.
• W1994092210 abstract "Mycophenolate mofetil is widely used in combination with either cyclosporine or tacrolimus for rejection prophylaxis in renal and heart transplant patients. Although not monitored routinely nearly to the degree that other agents such as cyclosporine or tacrolimus, there is an expanding body of experimental evidence for the utility of monitoring mycophenolic acid, the primary active metabolite of mycophenolate mofetil, plasma concentration as an index of risk for the development of acute rejection. The following are important experimentally-based reasons for recommending the incorporation of target therapeutic concentration monitoring of mycophenolic acid: (1) the MPA dose-interval area-under-the-concentration-time curve, and less precisely, MPA predose concentrations predict the risk for development of acute rejection; (2) the strong correlation between mycophenolic acid plasma concentrations and expression of important cell surface activation antigens, whole blood pharmacodynamic assays of lymphocyte proliferation and median graft rejection scores in a heart transplant animal model; (3) the greater than 10-fold interindividual variation of MPA area under the concentration time curve values in heart and renal transplant patients receiving a fixed dose of the parent drug; (4) drug-drug interactions involving other immunosuppressives are such that when switching from one to another (eg, from cyclosporine to tacrolimus or vice-versa) substantial changes in MPA concentrations can occur in patients receiving a fixed dose of the parent drug; (5) significant effects of liver and kidney diseases on the steady-state total and free mycophenolic acid area under the concentration time curve values; (6) the need to closely monitor mycophenolic acid when a major change in immunosuppression is planned such as steroid withdrawal. Current investigations are focused on determination of the most optimal sampling time and for mycophenolic acid target therapeutic concentration monitoring. Further investigations are needed to evaluate the pharmacologic activity of the newly described acyl glucuronide metabolite of mycophenolic acid which has been shown to inhibit, in vitro, inosine monophosphate dehydrogenase." @default.
• W1994092210 created "2016-06-24" @default.
• W1994092210 creator A5006541290 @default.
• W1994092210 creator A5023136222 @default.
• W1994092210 creator A5032275828 @default.
• W1994092210 creator A5077607916 @default.
• W1994092210 date "2001-02-01" @default.
• W1994092210 modified "2023-10-18" @default.
• W1994092210 title "Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients" @default.
• W1994092210 cites W1891570058 @default.
• W1994092210 cites W1971018450 @default.
• W1994092210 cites W1981535286 @default.
• W1994092210 cites W1985732783 @default.
• W1994092210 cites W2006870443 @default.
• W1994092210 cites W2008808603 @default.
• W1994092210 cites W2013670635 @default.
• W1994092210 cites W2016100084 @default.
• W1994092210 cites W2017010426 @default.
• W1994092210 cites W2044902647 @default.
• W1994092210 cites W2060752790 @default.
• W1994092210 cites W2067353313 @default.
• W1994092210 cites W2081355624 @default.
• W1994092210 cites W2081895090 @default.
• W1994092210 cites W2100422482 @default.
• W1994092210 cites W2114892521 @default.
• W1994092210 cites W2172121516 @default.
• W1994092210 cites W2320676056 @default.
• W1994092210 cites W2321360678 @default.
• W1994092210 cites W2336236972 @default.
• W1994092210 cites W2409639874 @default.
• W1994092210 cites W4230996310 @default.
• W1994092210 cites W4240011267 @default.
• W1994092210 cites W4254670117 @default.
• W1994092210 cites W50336179 @default.
• W1994092210 doi "https://doi.org/10.1016/s0009-9120(00)00184-3" @default.
• W1994092210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11239510" @default.
• W1994092210 hasPublicationYear "2001" @default.
• W1994092210 type Work @default.
• W1994092210 sameAs 1994092210 @default.
• W1994092210 citedByCount "104" @default.
• W1994092210 countsByYear W19940922102012 @default.
• W1994092210 countsByYear W19940922102013 @default.
• W1994092210 countsByYear W19940922102015 @default.
• W1994092210 countsByYear W19940922102016 @default.
• W1994092210 countsByYear W19940922102017 @default.
• W1994092210 countsByYear W19940922102018 @default.
• W1994092210 countsByYear W19940922102019 @default.
• W1994092210 countsByYear W19940922102020 @default.
• W1994092210 countsByYear W19940922102021 @default.
• W1994092210 countsByYear W19940922102023 @default.
• W1994092210 crossrefType "journal-article" @default.
• W1994092210 hasAuthorship W1994092210A5006541290 @default.
• W1994092210 hasAuthorship W1994092210A5023136222 @default.
• W1994092210 hasAuthorship W1994092210A5032275828 @default.
• W1994092210 hasAuthorship W1994092210A5077607916 @default.
• W1994092210 hasConcept C111113717 @default.
• W1994092210 hasConcept C112705442 @default.
• W1994092210 hasConcept C126322002 @default.
• W1994092210 hasConcept C2778033501 @default.
• W1994092210 hasConcept C2778330430 @default.
• W1994092210 hasConcept C2778849806 @default.
• W1994092210 hasConcept C2780035454 @default.
• W1994092210 hasConcept C2780272996 @default.
• W1994092210 hasConcept C2909675724 @default.
• W1994092210 hasConcept C2909935303 @default.
• W1994092210 hasConcept C2911091166 @default.
• W1994092210 hasConcept C71924100 @default.
• W1994092210 hasConcept C76318530 @default.
• W1994092210 hasConcept C98274493 @default.
• W1994092210 hasConceptScore W1994092210C111113717 @default.
• W1994092210 hasConceptScore W1994092210C112705442 @default.
• W1994092210 hasConceptScore W1994092210C126322002 @default.
• W1994092210 hasConceptScore W1994092210C2778033501 @default.
• W1994092210 hasConceptScore W1994092210C2778330430 @default.
• W1994092210 hasConceptScore W1994092210C2778849806 @default.
• W1994092210 hasConceptScore W1994092210C2780035454 @default.
• W1994092210 hasConceptScore W1994092210C2780272996 @default.
• W1994092210 hasConceptScore W1994092210C2909675724 @default.
• W1994092210 hasConceptScore W1994092210C2909935303 @default.
• W1994092210 hasConceptScore W1994092210C2911091166 @default.
• W1994092210 hasConceptScore W1994092210C71924100 @default.
• W1994092210 hasConceptScore W1994092210C76318530 @default.
• W1994092210 hasConceptScore W1994092210C98274493 @default.
• W1994092210 hasIssue "1" @default.
• W1994092210 hasLocation W19940922101 @default.
• W1994092210 hasLocation W19940922102 @default.
• W1994092210 hasOpenAccess W1994092210 @default.
• W1994092210 hasPrimaryLocation W19940922101 @default.
• W1994092210 hasRelatedWork W1974468096 @default.
• W1994092210 hasRelatedWork W1994092210 @default.
• W1994092210 hasRelatedWork W2022411944 @default.
• W1994092210 hasRelatedWork W2045868398 @default.
• W1994092210 hasRelatedWork W2092925654 @default.
• W1994092210 hasRelatedWork W2094916422 @default.
• W1994092210 hasRelatedWork W2100371816 @default.
• W1994092210 hasRelatedWork W2112164388 @default.
• W1994092210 hasRelatedWork W2312775958 @default.
• W1994092210 hasRelatedWork W3155072849 @default.

• next